by Scott Larrivee | Dec 29, 2025 | Blog
Shakespeare said the past is prologue. In that spirit, we submit this look back at 2025. It’s been a year of tremendous progress at Nusano. Our teams are working to enable fields ranging from healthcare to nuclear energy. Every step of the way, we are guided by...
by Scott Larrivee | Nov 6, 2025 | Blog
Nov. 6, 2025 – Nusano CEO, Chris Lowe, is the featured guest on the new edition of the Healthcare Technology Report podcast with RJ Lumba. The two discuss: Nusano’s breakthrough radioisotope production platform; The company’s endeavors beyond life...
by Scott Larrivee | Jun 26, 2025 | Blog
Nusano’s CEO, Chris Lowe, recently spoke to Ravi Kumar for the Connor Group’s Breakthrough Work podcast. The discussion covered: How Chris went from being CFO to leading Nusano as their CEO How Nusano technology is changing pharma, energy, and other...
by Scott Larrivee | May 29, 2025 | Podcast
In this episode of Talk Radioisotopes, host Scott Larrivee sits down with Sigal Kalmanson, CEO and Co-Founder of Starget Pharma, an early-stage company at the forefront of precision oncology. Starget is redefining the way radiopharmaceuticals are discovered and...
by Scott Larrivee | May 16, 2025 | Podcast
In this episode, Milton Lönnroth, Co-Founder and CEO, shares how Atley Solutions is changing the game for astatine-211, a promising isotope in cancer therapy. Atley supports radiopharmaceutical companies and researchers by enabling the scalable production and labeling...
